I. Introduction
As the problem of bacterial resistance becomes increasingly severe, the development of antimicrobial drugs with novel structures and new mechanisms of action has become a key focus in drug research. Due to issues such as single targets and the rapid development of resistance, the clinical efficacy of traditional antibiotics has been significantly challenged following prolonged use. Consequently, small-molecule compounds featuring new skeletal structures, new targets, and multi-mechanism characteristics are attracting increasing attention.
Salicylamide compounds are a class of aromatic amide molecules with a 2-hydroxybenzamide core. These compounds typically contain an ortho-hydroxyl group and an amide group, enabling the formation of intramolecular hydrogen bonds while exhibiting both lipophilicity and the ability to modulate polarity. Consequently, they are frequently employed as important structural building blocks in medicinal chemistry. In recent years, extensive research has demonstrated that, following rational structural modifications, salicylamide derivatives can exhibit significant antimicrobial activity, particularly showing potential against Gram-positive bacteria, drug-resistant bacteria, and mycobacteria.
It should be noted that salicylamide compounds do not constitute a mature class of antimicrobial drugs with a unified and well-defined mechanism of action, unlike β-lactams, aminoglycosides, or quinolones. Currently, their antimicrobial activity is primarily demonstrated at the “lead compound” level, and there are significant differences in the antimicrobial spectrum and modes of action among different derivatives. Therefore, it is necessary to systematically investigate their antimicrobial characteristics and potential mechanisms of action.
II. Antimicrobial Activity of Salicylamide Compounds
2.1 Characteristics of the Antimicrobial Spectrum
Existing research findings indicate that salicylamide compounds and their derivatives generally exhibit strong inhibitory effects against Gram-positive bacteria. Commonly susceptible species include Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Enterococcus species, and Bacillus species. In particular, certain structurally optimized derivatives have also demonstrated good in vitro activity against drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
In addition to Gram-positive bacteria, certain salicylamide derivatives also exhibit some inhibitory activity against mycobacteria, such as Mycobacterium tuberculosis and some nontuberculous mycobacteria. This has led to the salicylamide scaffold gradually gaining attention in the research of lead structures for antituberculosis drugs.
In contrast, the activity of these compounds against Gram-negative bacteria is generally weaker; for example, their inhibitory effects on common Gram-negative pathogens such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa are not significant. The primary reasons for this difference may be related to the additional outer membrane barrier, lower permeability, and stronger efflux pump activity characteristic of Gram-negative bacteria.
2.2 General Characteristics of Antimicrobial Activity
Overall, the antimicrobial activity of salicylamide compounds exhibits the following characteristics. First, they generally exhibit greater activity against Gram-positive bacteria than against Gram-negative bacteria; second, there are significant differences in activity among different derivatives, indicating that structural modifications have a decisive influence on their pharmacological effects; third, this class of compounds holds certain research value in the treatment of drug-resistant bacteria, biofilm-associated infections, and mycobacterial infections.
Therefore, the current understanding of the antimicrobial activity of salicylamide compounds should focus more on viewing them as a class of lead structures with development potential, rather than as a category of broad-spectrum antimicrobial agents with an established application system.
III. Mechanism of Action of Salicylamide Compounds
3.1 Interference with Cell Membrane Structure and Function
The cell membrane is one of the key targets through which many hydrophobic small molecules exert their antibacterial effects. Due to their strong lipophilicity, certain salicylamide derivatives can interact with bacterial cell membranes, inserting into the lipid bilayer and altering the membrane’s stability and fluidity. This process may lead to increased membrane permeability, a decrease in transmembrane potential, and the leakage of intracellular ions and small molecules, ultimately inhibiting bacterial growth and even causing cell death.
This membrane-related effect is more pronounced in Gram-positive bacteria, as they lack the outer membrane barrier characteristic of Gram-negative bacteria, allowing drug molecules to come into direct contact with the cell membrane more easily. It should be noted that not all salicylamide compounds rely on membrane disruption as their primary mechanism; this effect is more commonly observed in derivatives with higher hydrophobicity or specific substituents.
3.2 Interference with Energy Metabolism and Proton Motional Potential
Some salicylamide compounds contain phenolic hydroxyl groups, which may exhibit certain proton carrier properties, thereby affecting the bacterial transmembrane proton gradient and membrane potential. The proton motive force serves as a vital energy foundation for bacterial life processes such as ATP synthesis, substance transport, and flagellar motility; once disrupted, bacterial metabolic functions are significantly impaired.
Therefore, some salicylamide derivatives may exert antibacterial effects by weakening the proton motive force, affecting the efficiency of oxidative phosphorylation, or reducing ATP production levels. This mechanism of action is particularly likely to occur in conjunction with disruption of cell membrane function; however, current conclusions are largely based on in vitro experiments or mechanistic speculation and require further direct evidence to support them.
3.3 Metal Ion Chelation and Disruption of Metal Homeostasis
The hydroxyl group and amide carbonyl group in salicylamide compounds confer them with a certain ability to coordinate metal ions. Certain derivatives may bind to metal ions essential for bacterial growth, such as iron, copper, and zinc ions, thereby affecting bacterial uptake, storage, and utilization of these elements, and consequently disrupting metal homeostasis within the bacterium.
Metal ions play a critical role in various enzyme-catalyzed reactions, electron transfer processes, and redox equilibria. Therefore, disruption of metal homeostasis may not only inhibit the activity of metal-dependent enzymes but also affect the overall metabolic state of bacteria. In recent years, metal ion-related mechanisms have gradually become one of the key areas of research into the antibacterial effects of salicylamide compounds.
3.4 Targeting Specific Enzymes or Metabolic Pathways
In addition to specific membrane interactions, some salicylamide derivatives may also exert their effects by inhibiting specific enzymes or key biosynthetic pathways. Because these compounds possess hydrogen bond donors, acceptors, and an aromatic hydrophobic backbone, their structures are well-suited for binding to the active sites of various enzymes; consequently, they are frequently utilized in fragment-based drug design and lead optimization.
Existing research suggests that certain salicylamide derivatives may act on key targets in enzymes related to cell wall synthesis, fatty acid synthesis, nucleic acid metabolism, and Mycobacterium-specific cell wall lipid synthesis pathways. For mycobacteria, whose cell walls are complex and rich in lipids, salicylamide structures are considered to have potential value in anti-tuberculosis drug research due to their lipophilicity and good target binding affinity.
3.5 Anti-biofilm Activity
Biofilms are a key mechanism by which bacteria maintain drug resistance and survival in chronic and device-associated infections. Compared to free-floating bacteria, bacteria within biofilms exhibit higher resistance to antimicrobial agents. Therefore, the search for compounds with anti-biofilm activity is a major focus of current anti-infective research.
Some salicylamide derivatives have demonstrated the ability to inhibit bacterial adhesion, biofilm formation, and the stability of mature biofilms in studies. Their mechanisms of action may be related to disruption of membrane function, inhibition of quorum sensing, or metabolic stress. Although anti-biofilm activity cannot yet be generalized as a universal characteristic of this class of compounds, this area has shown significant potential for application.
IV. Structure-Activity Relationship Analysis
4.1 The Importance of the Ortho-Hydroxyl Group
The ortho-hydroxyl group is one of the key functional groups in the salicylamide backbone. This group not only forms intramolecular hydrogen bonds with the amide carbonyl group to stabilize the molecular conformation but also participates in hydrogen bonding with target proteins or metal ion coordination. Numerous studies have shown that the presence of the ortho-hydroxyl group plays a crucial role in maintaining or enhancing antimicrobial activity.
4.2 The Effect of the Amide Group on Activity
The amide group plays a crucial role in molecular recognition. On the one hand, the amide group acts as both a hydrogen bond donor and acceptor, enhancing the compound’s ability to interact with target enzymes or membrane components; on the other hand, it influences the molecule’s electronic distribution, polarity, and overall stability, thereby modulating its antimicrobial activity and pharmacokinetic properties.
4.3 The Role of Aromatic Ring Substituents
The type, number, and position of substituents on the aromatic ring significantly influence the antimicrobial activity of salicylamide compounds. Generally, the appropriate introduction of halogens, alkyl groups, or other hydrophobic groups can improve the molecule’s lipophilicity and membrane permeability, thereby enhancing antimicrobial activity. Certain electron-withdrawing groups may also improve binding affinity to targets by modulating the acidity of the phenolic hydroxyl group and the distribution of the molecular electron cloud.
However, an increase in antimicrobial activity does not imply that higher hydrophobicity is always better. If the molecule is too hydrophobic, it may lead to reduced water solubility, abnormal in vivo distribution, increased nonspecific binding, and enhanced cytotoxicity. Therefore, during structural optimization, a balance must be struck between activity, selectivity, and drug compatibility.
4.4 Spatial Conformation and Overall Physicochemical Properties
In addition to the functional groups themselves, physicochemical parameters such as the molecule’s spatial conformation, planarity, flexibility, and lipid-water partition coefficient also significantly influence its antimicrobial activity. Modern structure-activity relationship (SAR) studies suggest that the activity of salicylamide compounds arises from a comprehensive balance of multiple factors—including electronic effects, steric effects, hydrogen-bonding capacity, and hydrophobic interactions—rather than being determined by a single structural factor.
V. Research Value and Limitations
5.1 Research Value
The primary value of salicylamide compounds in antimicrobial drug development lies in their potential as lead structures. This class of compounds features a simple backbone, abundant sites for modification, and ease of introducing various pharmacophores, making them suitable for systematic structure-activity relationship studies and target-directed optimization. For drug-resistant bacteria, mycobacteria, and biofilm-associated infections, salicylamide derivatives may offer new chemical space and novel intervention strategies.
Furthermore, some salicylamide derivatives may exhibit multi-target activity, which holds theoretical significance for reducing the risk of resistance associated with traditional single-target drugs. Strategies such as molecular hybridization, prodrug design, or nanodelivery are also expected to further improve their pharmacodynamic and pharmacokinetic properties.
5.2 Limitations
Although salicylamide compounds have demonstrated certain antibacterial potential, their research is still subject to several limitations. First, many reports remain at the in vitro antibacterial experiment stage, lacking systematic in vivo efficacy evaluations and pharmacokinetic studies. Second, some of the more potent compounds suffer from issues such as insufficient selectivity, high cytotoxicity, or poor solubility. Third, due to the complex and inconsistent mechanisms of action of this class of compounds, their further development still requires more in-depth target identification and mechanistic studies.
Therefore, based on current research progress, salicylamide compounds are better suited as lead candidates in antimicrobial drug development rather than as a mature, established class of clinical antimicrobial agents.
VI. Conclusion
Salicylamide compounds represent a class of antimicrobial lead structures of significant research value. Their derivatives exhibit certain inhibitory activity against Gram-positive bacteria, certain drug-resistant bacteria, and mycobacteria, while their activity against Gram-negative bacteria is relatively weak. Unlike traditional classic antimicrobial drugs, this class of compounds does not share a completely unified mechanism of action. Their antimicrobial effects typically depend on specific structural features and may involve multiple pathways, including disruption of cell membrane function, disruption of energy metabolism, disruption of metal ion homeostasis, inhibition of specific enzymes, and anti-biofilm activity.
In terms of structure-activity relationships, ortho-hydroxyl groups, amide groups, aromatic ring substituents, and overall physicochemical properties significantly influence activity. Although challenges such as selectivity, solubility, toxicity, and insufficient in vivo evaluation remain, salicylamide compounds hold great promise in the development of novel antimicrobial agents, driven by ongoing advancements in target screening technologies, molecular design methods, and drug delivery strategies.